Daniel Huebschmann
Daniel Huebschmann
Clinician scientist, group leader National Center for Tumor Diseases (NCT) Heidelberg and German
Bestätigte E-Mail-Adresse bei dkfz-heidelberg.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
The landscape of genomic alterations across childhood cancers
SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ...
Nature 555 (7696), 321-327, 2018
5392018
The whole-genome landscape of medulloblastoma subtypes
PA Northcott, I Buchhalter, AS Morrissy, V Hovestadt, J Weischenfeldt, ...
Nature 547 (7663), 311-317, 2017
4502017
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, Genomes Consortium
Nature 578 (7793), 82, 2020
3982020
Integrative genomic and transcriptomic analysis of leiomyosarcoma
P Chudasama*, SS Mughal*, MA Sanders*, D Hübschmann*, I Chung, ...
Nature communications 9 (1), 1-15, 2018
912018
Evolutionary trajectories of IDHWT glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis
V Körber, J Yang, P Barah, Y Wu, D Stichel, Z Gu, MNC Fletcher, D Jones, ...
Cancer cell 35 (4), 692-704. e12, 2019
852019
Precision oncology based on omics data: the NCT Heidelberg experience
P Horak, B Klink, C Heining, S Gröschel, B Hutter, M Fröhlich, S Uhrig, ...
International journal of cancer 141 (5), 877-886, 2017
822017
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories
C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ...
Cancer cell 34 (6), 996-1011. e8, 2018
812018
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
S Gröschel, M Bommer, B Hutter, J Budczies, D Bonekamp, C Heining, ...
Molecular Case Studies 2 (6), a001180, 2016
512016
Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
N Ishaque, ML Abba, C Hauser, N Patil, N Paramasivam, ...
Nature communications 9 (1), 1-14, 2018
402018
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma
C López*, K Kleinheinz*, SM Aukema*, M Rohde*, SH Bernhart*, ...
Nature communications 10 (1), 1-19, 2019
372019
Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
S Gröschel*, D Hübschmann*, F Raimondi, P Horak, G Warsow, ...
Nature communications 10 (1), 1-9, 2019
302019
Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer
KM Giessler, K Kleinheinz, D Huebschmann, GP Balasubramanian, ...
Journal of Experimental Medicine 214 (7), 2073-2088, 2017
282017
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
N Paramasivam, D Hübschmann, UH Toprak, N Ishaque, M Neidert, ...
Acta neuropathologica 138 (2), 295-308, 2019
272019
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
R Hoefflin, B Lahrmann, G Warsow, D Hübschmann, C Spath, B Walter, ...
Nature communications 7 (1), 1-12, 2016
222016
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
R Wagener, J Seufert, F Raimondi, S Bens, K Kleinheinz, I Nagel, ...
Blood, The Journal of the American Society of Hematology 133 (9), 962-966, 2019
212019
ACEseq–allele specific copy number estimation from whole genome sequencing
K Kleinheinz, I Bludau, D Hübschmann, M Heinold, P Kensche, Z Gu, ...
BioRXiv, 210807, 2017
202017
Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature
F Sahm, UH Toprak, D Hübschmann, K Kleinheinz, I Buchhalter, M Sill, ...
Acta neuropathologica 134 (1), 155-158, 2017
182017
Large-scale uniform analysis of cancer whole genomes in multiple computing environments
CK Yung, BD O’Connor, S Yakneen, J Zhang, K Ellrott, K Kleinheinz, ...
BioRxiv, 161638, 2017
172017
The landscape of chromothripsis across adult cancer types
N Voronina, JKL Wong, D Hübschmann, M Hlevnjak, S Uhrig, CE Heilig, ...
Nature communications 11 (1), 1-13, 2020
162020
Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma
SM Dieter, C Heining, A Agaimy, D Huebschmann, D Bonekamp, B Hutter, ...
Annals of Oncology 28 (1), 142-148, 2017
162017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20